Augmentin Dosing Guidelines
For most common infections in adults, use Augmentin 875-125 mg every 12 hours or 500-125 mg every 8 hours; for children, use high-dose amoxicillin-clavulanate at 90 mg/kg/day (amoxicillin component) divided every 12 hours for resistant infections, or 45 mg/kg/day divided every 8-12 hours for standard coverage. 1
Adult Dosing
Standard Dosing (Normal Renal Function)
- Complicated UTI/Pyelonephritis: 875-125 mg every 8-12 hours 2, 3
- Acute Bacterial Rhinosinusitis: High-dose formulation (2 g orally twice daily) is recommended for initial empiric therapy 4
- Community-Acquired Pneumonia: Standard oral dosing for step-down therapy after clinical improvement 5
Renal Impairment Adjustments
Critical consideration: Amoxicillin and clavulanate have differential renal clearance, requiring careful dose adjustment 6
- CrCl 10-30 mL/min: Reduce frequency or dose; the amoxicillin-to-clavulanate ratio increases significantly (from 4.9:1 to 11.9:1) as renal function declines 6
- CrCl <10 mL/min or hemodialysis: Further dose reduction required; hemodialysis removes both components but clavulanate has higher extraction ratio (0.74 vs 0.44 for amoxicillin) 7
- Augmented renal clearance (ICU patients): May require higher doses or more frequent dosing; renal function is the primary determinant of exposure, not body weight 8
Pediatric Dosing
Standard Formulations
For acute otitis media and resistant pneumococcal infections: Use AUGMENTIN ES-600 at 90 mg/kg/day (amoxicillin component) divided every 12 hours for 10 days 1
- Body weight-based dosing (ES-600 formulation):
- 8 kg: 3.0 mL twice daily
- 12 kg: 4.5 mL twice daily
- 16 kg: 6.0 mL twice daily
- 20 kg: 7.5 mL twice daily
- 24 kg: 9.0 mL twice daily 1
Community-Acquired Pneumonia
- Outpatient (<5 years): Amoxicillin-clavulanate 90 mg/kg/day in 2 doses (amoxicillin component) 5
- Outpatient (≥5 years): 90 mg/kg/day in 2 doses, maximum 4 g/day 5
- Inpatient: Consider parenteral therapy initially, then step-down to oral when clinically improving 5
Critical Care Considerations
Post-cardiac surgery patients with augmented clearance: Require 4-hourly dosing instead of standard 6-hourly dosing to maintain adequate drug exposure, except when on vasopressors (which decrease clearance by 1/3) 9
Key Clinical Pitfalls
Formulation Confusion
AUGMENTIN ES-600 is NOT interchangeable with other Augmentin suspensions due to different clavulanate content:
- ES-600: 42.9 mg clavulanate per 5 mL
- 200 mg/5 mL suspension: 28.5 mg clavulanate per 5 mL
- 400 mg/5 mL suspension: 57 mg clavulanate per 5 mL 1
Oral Beta-Lactam Limitations
For complicated UTI, oral beta-lactams (including amoxicillin-clavulanate) show inferior outcomes compared to fluoroquinolones or trimethoprim-sulfamethoxazole in most comparative studies, despite optimized dosing 2, 3. Consider this when selecting oral step-down therapy.
Bioavailability Considerations
- Amoxicillin oral absorption: 80% 2, 3
- Clavulanate absorption: Variable 2, 3
- Urinary excretion: 50-70% (amoxicillin), 25-40% (clavulanate) 2, 3
- Administration: Take at start of meals to minimize GI intolerance and enhance clavulanate absorption 1
Penicillin Allergy Alternatives
Immediate-Type Reactions
- Recent (≤5 years) or severe reactions: Avoid all penicillins; use alternatives such as fluoroquinolones, cephalosporins (if no cross-reactivity), or clindamycin depending on infection type 10
- Non-severe reactions (>5 years ago): May consider controlled drug challenge with amoxicillin 500 mg under observation 10
Cross-Reactivity
For patients with documented penicillin allergy, cephalosporins may be used cautiously if the penicillin reaction was non-severe and occurred >5 years ago 10. However, avoid in patients with anaphylaxis or severe cutaneous adverse reactions (SCAR) to penicillins 10.
Duration of Therapy
- Acute bacterial rhinosinusitis (adults): 5-7 days 4
- Acute bacterial rhinosinusitis (children): 10-14 days 4
- Acute otitis media (children): 10 days 1
- Complicated UTI: Continue until 24-48 hours after defervescence and clinical improvement 2
Monitoring Requirements
- Hepatic function: Monitor at regular intervals in hepatically impaired patients 1
- Renal function: Essential in ICU patients and those with renal impairment; clearance changes rapidly with recovery or deterioration 8
- Clinical response: Reassess at 48-72 hours; consider alternative therapy if no improvement 4